Cargando…

Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role

Membranous nephropathy (MN) is the major cause of nephrotic syndrome with special pathological features, caused by the formation of immune complexes in the space between podocytes and the glomerular basement membrane. In idiopathic membranous nephropathy (IMN) the immune complexes are formed by circ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wenbin, Gao, Chang, Dai, Haoran, Zheng, Yang, Dong, Zhaocheng, Gao, Yu, Liu, Fei, Zhang, Zihan, Liu, Zhiyuan, Liu, Weijing, Liu, Baoli, Liu, Qingquan, Shi, Jialan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691064/ https://www.ncbi.nlm.nih.gov/pubmed/31447839 http://dx.doi.org/10.3389/fimmu.2019.01809

Ejemplares similares

How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?
por: Feng, Zhendong, et al.
Publicado: (2020)

Idiopathic Membranous Nephropathy: Glomerular Pathological Pattern Caused by Extrarenal Immunity Activity
por: Liu, Wenbin, et al.
Publicado: (2020)

The Potential Role of Regulatory B Cells in Idiopathic Membranous Nephropathy
por: Dong, Zhaocheng, et al.
Publicado: (2020)

Mechanism of herbal medicine on hypertensive nephropathy
por: Dong, Zhaocheng, et al.
Publicado: (2021)

A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy
por: Zhang, Pingna, et al.
Publicado: (2021)

Helper T Cells in Idiopathic Membranous Nephropathy
por: Zhao, Qihan, et al.
Publicado: (2021)

Exploring the Differences in Molecular Mechanisms and Key Biomarkers Between Membranous Nephropathy and Lupus Nephritis Using Integrated Bioinformatics Analysis
por: Dong, Zhaocheng, et al.
Publicado: (2022)

The Ameliorative Effect of Mahuang Fuzi and Shenzhuo Decoction on Membranous Nephropathy of Rodent Model is Associated With Autophagy and Wnt/β-Catenin Pathway
por: Gao, Yu, et al.
Publicado: (2022)

Research Progress on Mechanism of Podocyte Depletion in Diabetic Nephropathy
por: Dai, Haoran, et al.
Publicado: (2017)

Inhibition of the Wnt/β-catenin signaling pathway reduces autophagy levels in complement treated podocytes
por: Dong, Zhaocheng, et al.
Publicado: (2021)

Level of interleukin-35 in patients with idiopathic membranous nephropathy and its predictive value for remission time
por: Zhang, Na, et al.
Publicado: (2022)

Effect of Mahuang Fuzi and Shenzhuo Decoction on Idiopathic Membranous Nephropathy: A Multicenter, Nonrandomized, Single-Arm Clinical Trial
por: Dong, Zhaocheng, et al.
Publicado: (2021)

Alleviation by Mahuang Fuzi and Shenzhuo Decoction in High Glucose-Induced Podocyte Injury by Inhibiting the Activation of Wnt/β-Catenin Signaling Pathway, Resulting in Activation of Podocyte Autophagy
por: Dai, Haoran, et al.
Publicado: (2020)

MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
por: Zhou, Xiaoshan, et al.
Publicado: (2022)

Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy
por: Zhou, Xiaoshan, et al.
Publicado: (2023)

Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
por: Chen, Ruiying, et al.
Publicado: (2022)

The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: Du, Yu, et al.
Publicado: (2014)

Immunology of membranous nephropathy
por: Akiyama, Shin'ichi, et al.
Publicado: (2019)

Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
por: Guo, Yaling, et al.
Publicado: (2020)

Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels
por: Sun, Yuemeng, et al.
Publicado: (2022)

Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathy
por: Zhu, Huizi, et al.
Publicado: (2022)

Membranous nephropathy PLA2R+ associated with Chagas disease
por: Xavier-Júnior, José Cândido Caldeira, et al.
Publicado: (2015)

The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
por: Dahan, Karine, et al.
Publicado: (2017)

Horseshoe kidney with PLA2R-positive membranous nephropathy
por: Shi, Shuai-Shuai, et al.
Publicado: (2021)

Herbal Medicine “Shulifenxiao” Formula for Nephrotic Syndrome of Refractory Idiopathic Membranous Nephropathy
por: Cui, Hailan, et al.
Publicado: (2021)

Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: A cross-sectional study
por: Pang, Lu, et al.
Publicado: (2017)

PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy
por: Ge, Yong-Chun, et al.
Publicado: (2016)

HLA-DR, and not PLA2R, is expressed on the podocytes in kidney allografts in de novo membranous nephropathy
por: Wen, Jiqiu, et al.
Publicado: (2016)

Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults
por: Wu, Xueping, et al.
Publicado: (2018)

Response to immunosuppressive therapy in PLA(2)R- associated and non-PLA(2)R- associated idiopathic membranous nephropathy: a retrospective, multicenter cohort study
por: Wang, Jia, et al.
Publicado: (2017)

Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer
por: Deng, Le, et al.
Publicado: (2022)

Anti-PLA(2)R Antibodies in Chinese Patients with Membranous Nephropathy
por: Li, Xin, et al.
Publicado: (2016)

Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy
por: Geara, Abdallah S., et al.
Publicado: (2021)

Concurrent PLA2R-Associated Membranous Nephropathy and Antiglomerular Basement Membrane Disease
por: Jagannathan, Geetha, et al.
Publicado: (2022)

Cyclophosphamide induced early remission and was superior to rituximab in idiopathic membranous nephropathy patients with high anti-PLA2R antibody levels
por: Xue, Cheng, et al.
Publicado: (2023)

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy
por: Chen, Yang, et al.
Publicado: (2023)

Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
por: Logt, Anne-Els van de, et al.
Publicado: (2021)

Gene alterations in monocytes are pathogenic factors for immunoglobulin a nephropathy by bioinformatics analysis of microarray data
por: Guo, Yingbo, et al.
Publicado: (2018)

Correction: The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s3a4h1c488nj1q5uvmecitsgs0